Skip to main content

Table 1 Parvovirus B19 prevalence in β-thalassemia patients

From: A literature review on the parvovirus B19 infection in sickle cell anemia and β-thalassemia patients

First author

Country

Year

Sample size

Mean age (year)

Sexa

IgG prevalence (%)

IgM prevalence (%)

Genotype

PCR prevalence

Method

Study design

Ref.

Case

Control

Male

Female

Case

Control

Case

Control

Ghwass

Egypt

2016

55

6.2± 13.25

29

26

18.2

14.5

ELISA

CS

[19]

Slavov

Brazil

2012

39

100

23.56

(range: 3–45)

59%

41%

35.9

60

1A

15.3

sequencing, ELISA, qPCR,

CS

[20]

Kishore

India

2011

90

32

8 (range 2-18)

55

35

81

21

41.1

6.2

ELISA

CS

[21]

Arabzadeh

Iran

2017

150

30.4

75

75

I

4

Real-time PCR

CS

[22]

  1. aSome studies reported the number of male/female and another reported percentage
  2. PCR polymerase chain reaction, CS cross-sectional, ELISA enzyme-linked immunosorbent assay, qPCR quantitative PCR